Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247013 · ClinicalTrials.gov registry record · Phase 1
Automated Tele Counseling for Screening Mammography
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 2,120
- Enrollment target
NCT00247013: Completed Phase 1 study, sponsored by Boston Medical Center.
NCT00247013 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 2,120 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (3433% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247013, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2,120 participants
- Enrollment target
Study Summary
The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74. The system will not only help in scheduling appointments but will help women in overcoming any barriers that may deter them from having the procedure at all. The programs are designed to be user friendly and easy to implement in clinical practice.
Interventions
- BEHAVIORAL Breast Cancer Screening Compliance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,120 participants |
| Start Date | 1996-01 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
What the finished NCT00247013 record still lists
NCT00247013 is an interventional study that assigns participants to a tested intervention. Its 2,120 participants enrollment target places it among the larger protocols in the corpus, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (3433% higher).
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Screening Compliance is the first listed.
NCT00247013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00247013 about?
NCT00247013 is a clinical study titled "Automated Tele Counseling for Screening Mammography". The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74. The system will not only help in scheduling appointments but will help women in overcom...
What is the current status of trial NCT00247013?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2,120 participants. The study started on 1996-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00247013?
The interventions under investigation include: Breast Cancer Screening Compliance (BEHAVIORAL).
Who is sponsoring clinical trial NCT00247013?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00247013's enrollment target sits among peer trials
2,120 3rd of 2000 higher than 1,998 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05916430 · 2,120 participants
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
- NCT05681624 · 2,124 participants · NA
Maternal Oxygen Supplementation for Intrauterine Resuscitation
- NCT07431281 · 2,130 participants · Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia